Birth Control News and Research

RSS

VDF, CDC and VDC to educate women about gender-specific DVT risks

Deep vein thrombosis (DVT) is a blood clot in the deep veins in the legs. These clots can break loose and travel to the lungs, causing a potentially fatal pulmonary embolism (PE). Even when they don't, they can cause permanent damage to the leg veins that results in long-term pain, swelling, and disability of the leg.

9 Dec 2011

Viewpoints: Politics overtakes Plan B; Gingrich's entitlement plans; Cheeseburgers and death

Once again, the politics of birth control have trumped science and sound public policy. On Wednesday, the Obama administration overruled a carefully reasoned decision by the Food and Drug Administration to make the so-called morning-after pill available without prescription to adolescent girls below the age of 17.

9 Dec 2011

Sebelius overturns FDA on morning after pill access

The Health and Human Services Secretary Kathleen Sebelius this Wednesday has overturned the Food and Drug Administration's plan to remove the age limit on who can buy Teva Pharmaceutical Industries Ltd's Plan B One-Step pill – commonly known as the “morning after pill” without a prescription.

8 Dec 2011

HHS: Plan B access will stay limited

The Department of Health and Human Services announced today that the morning-after pill, known as Plan B, will continue to be kept behind the pharmacy counter and girls younger than 17 will continue to need a prescription to obtain it.

8 Dec 2011

Positive results from Genentech's pertuzumab plus Herceptin Phase III study on HER2-positive mBC

Genentech, a member of the Roche Group, today announced results from CLEOPATRA, the first randomized Phase III study of the investigational HER2-targeted medicine pertuzumab.

8 Dec 2011

Updated data from Novartis Afinitor plus everolimus Phase III study on advanced breast cancer

Updated results of a Phase III study of Afinitor (everolimus) tablets plus exemestane, a hormonal therapy, show everolimus provided additional time women with advanced breast cancer lived without their disease progressing.

8 Dec 2011

Reuters examines role of family planning at Durban climate change talks

"[W]ith studies suggesting that 215 million women around the world want -- but cannot get -- effective contraception, making sure birth control methods are available to those who want them could be one of the cheapest, fastest and most effective ways of addressing climate change, experts said at the U.N. climate conference in Durban" this week, AlertNet reports.

7 Dec 2011

Novartis to showcase 160 presentations on breast cancer, hematological disease drugs at SABCS and ASH

Novartis Pharmaceuticals Corporation will showcase more than one hundred and sixty presentations on data from its robust oncology portfolio at two key medical congresses this month, demonstrating significant advances for patients with cancers and hematological diseases.

3 Dec 2011

First Edition: December 2, 2011

In today's headlines, reports on congressional efforts to extend a payroll tax break and other work Congress must do before the end of the year -- including the Medicare doc fix.

2 Dec 2011

Genentech announces results from pertuzumab studies on HER2-positive breast cancer

Genentech, a member of the Roche Group, today announced the company will present results from studies of its investigational medicine pertuzumab in HER2-positive breast cancer at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium December 6-10.

30 Nov 2011

FDA approves Watson's ANDA for generic Yaz oral contraceptive

Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration for its Abbreviated New Drug Application for Vestura (3 mg drospirenone and 0.02 mg ethinyl estradiol), a generic version of Bayer's Yaz oral contraceptive product.

29 Nov 2011

Viewpoints: What now for deficit cutters; Berwick's replacement

There's already a bipartisan group of senators, the maverick "Gang of Six," that is volunteering to produce a new compromise package. ... The Gang of Six plan won't make anybody happy.

28 Nov 2011

Democrats ask Obama not to dilute contraceptive benefits

Democratic lawmakers, fearful that President Obama is on the verge of significantly diluting a proposed regulation that would give millions of women access to birth control without out-of-pocket insurance charges, are furiously lobbying the White House to hold the line.

24 Nov 2011

First Edition: November 23, 2011

Today's early morning highlights from the major news organizations include an examination of changes in Medicare that the Democrats have endorses and a Kansas abortion case.

23 Nov 2011

Is economic crunch the best birth control?

Experts feel it is the economic strain that is responsible for the U.S. birth rate decline that has been consistently falling for the third consecutive year.

22 Nov 2011

FDA Commissioner revokes approval of Genentech's Avastin for treatment of mBC

Genentech, a member of the Roche Group, announced today that the FDA Commissioner is revoking the approval of Avastin (bevacizumab) for the treatment of mBC in the United States.

18 Nov 2011

Supreme Court could announce today its plans for the health law

After a year and a half of legal skirmishing, President Obama's embattled health care law has arrived at the Supreme Court riding a surprising winning streak and carrying a constitutional stamp of approval from prominent conservative judges. … The Supreme Court is expected to announce as soon as Monday that it will hear the Florida case, the largest and broadest challenge to the Patient Protection and Affordable Care Act.

15 Nov 2011

Viewpoints: Conservative legal path on health law; Romney's plans for Medicare and vets; States moving on reform

A federal appeals court in the District of Columbia endorsed the constitutionality of health care reform this week in an opinion as notable for its authorship as for its legal reasoning. The majority opinion in the 2-to-1 decision was written by Judge Laurence Silberman, a stalwart of conservative jurisprudence whose views are said to be enormously influential in conservative legal circles.

14 Nov 2011

Longer looks: Do extra brain cells offer a clue to autism?; doctors leaving medicine

There's growing evidence that the brains of autistic children are very different from the brains of other youngsters. Now a new study that found an excess of brain cells in children with autism comes closer to pinpointing the origins of the condition: in utero versus in toddlerhood. In research reported in the Journal of the American Medical Association (JAMA), scientists at the University of California, San Diego, found that autistic children have about 67% more nerve cells in a part of the brain known as the prefrontal cortex than children without autism.

11 Nov 2011

Loss of 'personhood' amendment in Miss. raises questions about anti-abortion strategy

The group that supported the controversial ballot issue says it wants to go forward in other states next year. Meanwhile a judge in Kansas threw out criminal charges against Planned Parenthood clinic.

11 Nov 2011

Birth Control News and Research

VDF, CDC and VDC to educate women about gender-specific DVT risks

Viewpoints: Politics overtakes Plan B; Gingrich's entitlement plans; Cheeseburgers and death

Sebelius overturns FDA on morning after pill access

HHS: Plan B access will stay limited

Positive results from Genentech's pertuzumab plus Herceptin Phase III study on HER2-positive mBC

Updated data from Novartis Afinitor plus everolimus Phase III study on advanced breast cancer

Reuters examines role of family planning at Durban climate change talks

Novartis to showcase 160 presentations on breast cancer, hematological disease drugs at SABCS and ASH

First Edition: December 2, 2011

Genentech announces results from pertuzumab studies on HER2-positive breast cancer

FDA approves Watson's ANDA for generic Yaz oral contraceptive

Viewpoints: What now for deficit cutters; Berwick's replacement

Democrats ask Obama not to dilute contraceptive benefits

First Edition: November 23, 2011

Is economic crunch the best birth control?

FDA Commissioner revokes approval of Genentech's Avastin for treatment of mBC

Supreme Court could announce today its plans for the health law

Viewpoints: Conservative legal path on health law; Romney's plans for Medicare and vets; States moving on reform

Longer looks: Do extra brain cells offer a clue to autism?; doctors leaving medicine

Loss of 'personhood' amendment in Miss. raises questions about anti-abortion strategy

Industry Focus eBook - Cell biology (5th edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News